These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 18713777)

  • 1. Hypertrophic cardiomyopathy and athlete's heart: a tale of two entities.
    Martín M; Reguero JJ; Castro MG; Coto E; Hernández E; Carro A; Calvo D; de la Tassa CM
    Eur J Echocardiogr; 2009 Jan; 10(1):151-3. PubMed ID: 18713777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
    Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
    Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol.
    Ng CT; Chee TS; Ling LF; Lee YP; Ching CK; Chua TS; Cheok C; Ong HY
    Europace; 2011 Jun; 13(6):883-8. PubMed ID: 21486912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
    Maron BJ
    Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart.
    Calore C; Zorzi A; Corrado D
    J Electrocardiol; 2015; 48(3):373-9. PubMed ID: 25595718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for hypertrophic cardiomyopathy in young athletes.
    Corrado D; Basso C; Schiavon M; Thiene G
    N Engl J Med; 1998 Aug; 339(6):364-9. PubMed ID: 9691102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sudden cardiac death in athletes is usually caused by undiagnosed heart disease. Cardiac screening of young athletes under discussion].
    Börjesson M; Nylander E
    Lakartidningen; 2005 Feb 21-27; 102(8):560-3. PubMed ID: 15786908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.
    McLeod CJ; Ackerman MJ; Nishimura RA; Tajik AJ; Gersh BJ; Ommen SR
    J Am Coll Cardiol; 2009 Jul; 54(3):229-33. PubMed ID: 19589435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Athlete's heart and hypertrophic cardiomyopathy: contribution on clinical and morphologic differentiation].
    Bahlmann E; Kuck KH; Nienaber CA
    Dtsch Med Wochenschr; 2015 Jul; 140(15):1158-64. PubMed ID: 26230069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy--sports-related aspects of diagnosis, therapy, and sports eligibility.
    Hipp AA; Heitkamp HC; Röcker K; Dickhuth HH
    Int J Sports Med; 2004 Jan; 25(1):20-6. PubMed ID: 14750008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic electrocardiographic changes in a junior athlete with unpredictable hypertrophic cardiomyopathy.
    de Gregorio C; Magliarditi A; Magaudda L
    Int J Cardiol; 2009 Nov; 137(3):e51-3. PubMed ID: 19411118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Athlete's heart or hypertrophic cardiomyopathy?
    Lauschke J; Maisch B
    Clin Res Cardiol; 2009 Feb; 98(2):80-8. PubMed ID: 18853091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: ask athletes these 9 questions.
    deWeber K; Beutler A
    J Fam Pract; 2009 Nov; 58(11):576-84. PubMed ID: 19891935
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
    Rowin EJ; Maron BJ; Appelbaum E; Link MS; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2012 Oct; 110(7):1027-32. PubMed ID: 22809754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thick hearts, high stakes, great uncertainties: screening athletes for hypertrophic cardiomyopathy.
    Baggish A; Thompson PD
    Heart; 2009 Mar; 95(5):345-7. PubMed ID: 18977800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.